0

CS1

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1448009946
CAS1448009-94-6
Molecular Weight252.26
InChI KeyLDFFDYWHCCDSBO-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 20 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to light brown
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in Systemic Lupus Erythematosus and Cancer

Joseph D Malaer, Armando M Marrufo, Porunelloor A Mathew

Clin Immunol. 2019 Jul;204:50-56.

PMID: 30347240

1

A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells Against Multiple Myeloma

Wing Keung Chan, Siwen Kang, Youssef Youssef, Erin N Glankler, Emma R Barrett, Alex M Carter, Elshafa H Ahmed, Aman Prasad, Luxi Chen, Jianying Zhang, Don M Benson Jr, Michael A Caligiuri, Jianhua Yu

Cancer Immunol Res. 2018 Jul;6(7):776-787.

PMID: 29769244

1

CS1 (SLAMF7, CD319) Is an Effective Immunotherapeutic Target for Multiple Myeloma

Joseph D Malaer, Porunelloor A Mathew

Am J Cancer Res. 2017 Aug 1;7(8):1637-1641.

PMID: 28861320

1

Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma

Xiuli Wang, Miriam Walter, Ryan Urak, Lihong Weng, Christian Huynh, Laura Lim, ChingLam W Wong, Wen-Chung Chang, Sandra H Thomas, James F Sanchez, Lu Yang, Christine E Brown, Flavia Pichiorri, Myo Htut, etc.

Clin Cancer Res. 2018 Jan 1;24(1):106-119.

PMID: 29061640

1

Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma

Francesca Bonello, Roberto Mina, Mario Boccadoro, Francesca Gay

Cancers (Basel). 2019 Dec 19;12(1):15.

PMID: 31861548

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode